Evidence map›Paper›PMID 39634338›Full record

ArticleBiochemistry and biophysics reports2024

Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids.

Sagar Rathee, Madhan Vishal Rajan, Simran Sharma, Gururao Hariprasad

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sagar RatheeDepartment of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Madhan Vishal RajanDepartment of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Simran SharmaDepartment of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Gururao HariprasadDepartment of Biophysics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatidylinositol 3-kinases (PI3K) form a family of lipid kinases that catalyze the phosphorylation of 3-hydroxyl group of the inositol ring of phosphatidylinositol and its derivatives. It is implicated in inflammatory disorders and cancer thus making it an attractive drug target. Crystal structure of human PI3Kγ was taken and structure was completed using MODELLER and validated using PROCHECK. Stilbenoid molecules, piceatannol and resveratrol, were docked to kinase domain of PI3Kγ using AutoDock Vina and docked complexes were subjected to molecular dynamic simulations using Desmond suite of programmes. Based on the structural analysis of these complexes, modified derivatives of the native molecules were designed, docked and molecular dynamic simulations were performed. Kinase domain has a bi-lobar structure with ATP binding site lying in the cleft connecting the two lobes that are primarily composed of 12 α-helices and 8 β-strands. Piceatannol and resveratrol bind at the ATP binding site, with one its rings in a position primarily occupied by adenine of ATP making a hydrogen bond with backbone of Val882. Molecules also make interactions with Lys833 and several isoleucine residues. Interactions with Ser806 appear to be crucial for the loop conformation and compactness. Derivative molecules of stilbenoids also occupy the ATP binding cleft and the chemical modifications result in hydrogen bonded interactions to Glu880, and ionic interactions to Lys833 and Lys808 thereby enhancing their potencies in comparison to native molecules. Biophysical parameters and quality of interactions of stilbenoid derivatives augurs well for development of potent and specific inhibitory molecules against PI3Kγ enzyme.

Indexed as

Drug targetInteractionsPhosphatidylinositol 3-kinase γPotencySpecificityStilbenoidsStructural based drug design

Identifiers

PMID39634338
PMCPMC11616550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.